Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes

OBJECTIVE: The main purpose of this study was to investigate the association of serum SerpinB1 levels and various parameters in patients with type 2 diabetes. The effect of canagliflozin (a sodium glucose cotransporter 2 (SGLT2) inhibitor), which can decrease circulating insulin levels, on serum Ser...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Diabetes Res Care
Main Authors: Takebayashi, Kohzo, Hara, Kenji, Terasawa, Tomoko, Naruse, Rika, Suetsugu, Mariko, Tsuchiya, Takafumi, Inukai, Toshihiko
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Cardiovascular and Metabolic Risk
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5128937/
https://ncbi.nlm.nih.gov/pubmed/27933185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2016-000274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados